While studies have explored the connection between the effectiveness of concurrent chemotherapy and radiotherapy and HIF-1 alpha expression in locally advanced cervical cancer, research on how HIF-1 alpha expression influences the prognosis of metastatic cervical cancer patients undergoing anti-VEGF-based therapy is absent [15]. This evidence concerns the gene VEGFA and cervical carcinoma.